Terms ending in 2038
Every in-force patent on Sanofi's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,156,601 | In Vitro Neonatal Biomimetic (NMIMIC) Model and Methods of Using Same In force · High confidence | Sanofi Pasteur Vaxdesign Corporation | In force | High confidence | |
| US 12,630,617 | Serum Albumin Binders In force · High confidence | Sanofi | In force | High confidence | |
| US 11,242,384 | Anti-Tgf-Beta Antibodies and Their Use In force · High confidence | Sanofi | In force | High confidence | |
| US 12,151,081 | Medicament Delivery System In force · Medium confidence | Sanofi | In force | Medium confidence | |
| US 11,116,832 | Modification of Engineered Influenza Hemagglutinin Polypeptides In force · High confidence | Sanofi Vaccines US Inc. | In force | High confidence | |
| US D976,921 | Display Panel Portion with a Graphical User Interface In force · High confidence | Sanofi US Services Inc. | In force | High confidence | |
| US 10,538,567 | Compounds as Peptidic Trigonal GLP1/GLUCAGON/GIP Receptor Agonists In force · High confidence | Sanofi | In force | High confidence | |
| US 10,626,169 | Multispecific binding molecules having specificity to dystroglycan and laminin-2 In force · High confidence | Sanofi | In force | High confidence | |
| US 12,454,555 | Engineered Influenza Antigenic Polypeptides and Immunogenic Compositions Thereof In force · High confidence | Sanofi Vaccines US Inc. | In force | High confidence | |
| US 10,392,366 | Azetidine Compounds as GPR119 Modulators for the Treatment of Diabetes, Obesity, Dyslipidemia and Related Disorders In force · High confidence | Sanofi | In force | High confidence | |
| 71 more term ends in 2038 · Pro | |||||
10 of 81 patents shown. Soonest term end first, then patent number.
Pro members see all 81.
73 of these are in force and held by Sanofi.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.